# FDA Inspection 1004860 - Zimmer Biomet Atlanta - March 17, 2017

Source: https://www.keypedia.com/records/fda_inspections/zimmer-biomet-atlanta/a2cee39a-3b00-4650-ac8e-33cd964f30ae
Source feed: FDA_Inspections

> FDA Inspection 1004860 for Zimmer Biomet Atlanta on March 17, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1004860
- Company Name: Zimmer Biomet Atlanta
- Inspection Date: 2017-03-17
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1004860 - 2017-03-17](https://www.keypedia.com/records/fda_inspections/zimmer-biomet-atlanta/763a10b4-6503-4f8b-905e-33d52f2e212c)
- [FDA Inspection 913079 - 2015-02-04](https://www.keypedia.com/records/fda_inspections/zimmer-biomet-atlanta/291d640a-66fb-434f-a189-7e05a29697da)
- [FDA Inspection 875623 - 2014-04-21](https://www.keypedia.com/records/fda_inspections/zimmer-biomet-atlanta/88f96998-844f-482f-93f1-92651f79f03b)

Company: https://www.keypedia.com/companies/zimmer-biomet-atlanta/40120254-318c-431d-a9de-a26412c052de

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d